2m 2m 2m 2m 2m 2m 2m
Exelixis (EXEL)
NASDAQ
$54.29+$0.21 (+0.39%)
Price as of Aug 21, 2026 7:44 PM EDT- $13.4BMarket Cap
- 39.99%1-Year Change
- BiotechnologyIndustry
Exelixis (EXEL)
$54.29+$0.21 (+0.39%)
Earnings Score
Valuation | EXEL | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | 1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | EXEL | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 14.34% | ||
12-Month Momentum | 43.76% | ||
3-Month Risk Adjusted Momentum | 118.16% | ||
12-Month Risk Adjusted Momentum | 128.22% |
True Yield
Valuation | EXEL | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 7.70% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | EXEL | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 12 |